Skip to main content
. 2024 Feb 29;15:1349745. doi: 10.3389/fphar.2024.1349745

FIGURE 3.

FIGURE 3

Silibinin has the potential to treat breast cancer by promoting apoptosis, disrupting the cell cycle, inhibiting cancer cell division, and reducing angiogenic factors. It also has anti-inflammatory effects and inhibits metastasis, interacting with key signaling pathways.